Cell-preservation technique could make CAR-T cell therapy more accessible

Immune cells that are engineered to attack cancer cells, known as CAR-T cells, are used to treat some types of blood cancer. However, only about 5% of hospitals in the United States can generate and deliver CAR-T cells to patients. For many patients, this means the cells need to be frozen and shipped long distances.

Read it at Medical Xpress ↗

← Front page